Reference
Karbal B. Direct Healthcare Professional Communication - Mitomycin-C Kyowa 40 mg restricted to intravesical administration only for treatment of superficial bladder cancer. Internet Document : [3 pages], 9 Oct 2019. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information---mitomycin-c-kyowa-40-mg.pdf?sfvrsn=0
Rights and permissions
About this article
Cite this article
Intravesicular mitomycin restricted to bladder cancer only. Reactions Weekly 1776, 1 (2019). https://doi.org/10.1007/s40278-019-70159-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70159-5